Adamis Pharmaceuticals Corp (ADMP):企業の財務・戦略的SWOT分析

◆英語タイトル:Adamis Pharmaceuticals Corp (ADMP) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15109
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc, is a biopharmaceutical company that develops therapies in areas of respiratory disease and allergy. The company offers pipeline product, epinephrine pre-filled syringe is developed for anaphylactic reactions such as insect stings, foods, medications and latex. It also offers pipeline products such as APC-2000 for the treatment of bronchospasms; APC-1000 and APC-4000 for the treatment of asthma and chronic obstructive pulmonary disease; and steroid product for the treatment of allergic rhinitis. The company has operations in Phoenix and San Diego. Adamis is headquartered in San Diego, California, the US.

Adamis Pharmaceuticals Corp Key Recent Developments

Nov 09,2018: Adamis Pharmaceuticals announces third quarter 2018 financial results and business update
Aug 27,2018: Adamis Pharmaceuticals Provides Business Update
Aug 10,2018: Adamis Pharmaceuticals announces second quarter 2018 financial results and business update
May 10,2018: Adamis Pharmaceuticals Announces First Quarter 2018 Financial Results and Business Update
Mar 15,2018: Adamis Pharmaceuticals Discusses 2017 Highlights and Business Update

This comprehensive SWOT profile of Adamis Pharmaceuticals Corp provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Adamis Pharmaceuticals Corp including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Adamis Pharmaceuticals Corp – Key Information
Adamis Pharmaceuticals Corp – Overview
Adamis Pharmaceuticals Corp – Key Employees
Adamis Pharmaceuticals Corp – Key Employee Biographies
Adamis Pharmaceuticals Corp – Key Operational Heads
Adamis Pharmaceuticals Corp – Major Products and Services
Adamis Pharmaceuticals Corp – History
Adamis Pharmaceuticals Corp – Company Statement
Adamis Pharmaceuticals Corp – Locations And Subsidiaries
Adamis Pharmaceuticals Corp – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Adamis Pharmaceuticals Corp – Business Description
Adamis Pharmaceuticals Corp – Corporate Strategy
Adamis Pharmaceuticals Corp – SWOT Analysis
SWOT Analysis – Overview
Adamis Pharmaceuticals Corp – Strengths
Adamis Pharmaceuticals Corp – Weaknesses
Adamis Pharmaceuticals Corp – Opportunities
Adamis Pharmaceuticals Corp – Threats
Adamis Pharmaceuticals Corp – Key Competitors

Section 3 – Company Financial Performance Charts

Adamis Pharmaceuticals Corp – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Adamis Pharmaceuticals Corp, Key Information
Adamis Pharmaceuticals Corp, Key Ratios
Adamis Pharmaceuticals Corp, Share Data
Adamis Pharmaceuticals Corp, Major Products and Services
Adamis Pharmaceuticals Corp, History
Adamis Pharmaceuticals Corp, Key Employees
Adamis Pharmaceuticals Corp, Key Employee Biographies
Adamis Pharmaceuticals Corp, Key Operational Heads
Adamis Pharmaceuticals Corp, Other Locations
Adamis Pharmaceuticals Corp, Subsidiaries
Adamis Pharmaceuticals Corp, Key Manufacturing facilities
Adamis Pharmaceuticals Corp, Key Competitors
Adamis Pharmaceuticals Corp, SWOT Analysis
Adamis Pharmaceuticals Corp, Ratios based on current share price
Adamis Pharmaceuticals Corp, Annual Ratios
Adamis Pharmaceuticals Corp, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Adamis Pharmaceuticals Corp, Performance Chart
Adamis Pharmaceuticals Corp, Ratio Charts

★海外企業調査レポート[Adamis Pharmaceuticals Corp (ADMP):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Abu Dhabi Investment Authority:電力:M&Aディール及び事業提携情報
    Summary Abu Dhabi Investment Authority (ADIA) is a sovereign wealth fund owned and managed by Emirate of Abu Dhabi. It invests directly in global financial markets along with trusted partner’s selected external managers. The company’s investment portfolio includes developed equities, small cap equit …
  • Petra Energy Berhad (PENERGY):石油・ガス:M&Aディール及び事業提携情報
    Summary Petra Energy Berhad (Petra Energy) is an integrated brown field service provider for the upstream oil and gas industry. The company offers services such as designing, procurement, engineering, installation, fabrication, commissioning, maintenance, construction and project management. It also …
  • Fluidigm Corp (FLDM):企業の財務・戦略的SWOT分析
    Summary Fluidigm Corp (Fluidigm), formerly Mycometrix Corp, develops, manufactures, and markets life science analytical and preparatory systems for mass cytometry, high-throughput genomics, and single-cell genomics markets. The company offers analytical systems and instruments, preparatory instrumen …
  • Continental AG:企業の戦略・SWOT・財務分析
    Continental AG - Strategy, SWOT and Corporate Finance Report Summary Continental AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Pabulum Limited:企業の戦略・SWOT・財務分析
    Pabulum Limited - Strategy, SWOT and Corporate Finance Report Summary Pabulum Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • NeuroVive Pharmaceutical AB (NVP):企業の財務・戦略的SWOT分析
    Summary NeuroVive Pharmaceutical AB (NeuroVive), formerly NeuroPharma i Sverige AB focuses on the research and development of mitochondrial therapies. The company’s programs include NeuroSTAT, a clinical phase II drug candidate for the prevention of traumatic brain injury; and phase I KL1333, a nove …
  • Chemetall GmbH:企業の戦略的SWOT分析
    Chemetall GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Cerus Corp (CERS):企業の製品パイプライン分析
    Summary Cerus Corp (Cerus) is a biomedical products company that focuses in the field of blood transfusion safety. It develops and commercializes Intercept Blood System, which reduces the risk of transfusion-transmitted infections by inactivating a wide range of pathogens including viruses, bacteria …
  • China Southern Airlines Company Limited:企業のM&A・事業提携・投資動向
    China Southern Airlines Company Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Southern Airlines Company Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed re …
  • IntelGenx Corp:企業のM&A・事業提携・投資動向
    IntelGenx Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's IntelGenx Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • HSN Inc:企業の戦略的SWOT分析
    HSN Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Nuri Telecom Co., Ltd. (040160):企業の財務・戦略的SWOT分析
    Nuri Telecom Co., Ltd. (040160) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • CullenFrost Bankers Inc (CFR):企業の財務・戦略的SWOT分析
    CullenFrost Bankers Inc (CFR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Tribal Group Plc (TRB):企業の財務・戦略的SWOT分析
    Tribal Group Plc (TRB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Medicines for Malaria Venture:企業のM&A・事業提携・投資動向
    Medicines for Malaria Venture - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Medicines for Malaria Venture Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Nissan Motor Co., Ltd.:企業の戦略・SWOT・財務分析
    Nissan Motor Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nissan Motor Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Indequity Group Limited:企業の戦略・SWOT・財務分析
    Indequity Group Limited - Strategy, SWOT and Corporate Finance Report Summary Indequity Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Pharm-Olam International Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Pharm-Olam International Ltd (Pharm-Olam) is a contract research organization (CRO) which offers clinical research services to the pharmaceutical, biotechnology and medical device industries. The organization's service offerings include medical writing, monitoring, regulatory and ethics subm …
  • Triple Energy Ltd (TNP):企業の財務・戦略的SWOT分析
    Summary Triple Energy Ltd (Triple Energy) is an oil and gas company that explores for natural resources. The company invests in oil and gas projects in the conventional and unconventional sectors such as coal seam gas and shale oil and gas, along with power generation. It offers project such as CFT …
  • SK Kaken Co Ltd (4628):企業の財務・戦略的SWOT分析
    SK Kaken Co Ltd (4628) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆